Clinical Trials in Miami

Showing 4321-4340 of 5,722 trials

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

NCT00068809

This study will determine if taking anti-HIV drugs 4 days a week will control HIV-1 viral replication in patients who have already had at least 6 months of documented viral suppression with full-time treatment. If this strategy is shown to be safe in this study, a larger study will be undertaken to determine if the strategy can decrease overall drug exposure and help young people adjust more easily to a chronic medication schedule.

HIV Infections

University of North Carolina, Chapel Hill31 participantsStarted Jul 2003

Los Angeles, California, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +6 more locations

COMPLETED< 1 mile

HIV Treatment-Readiness Measure (HTRM) Validation

NCT00686049

The goal of this study is to assess the reliability of the HIV Treatment Readiness Measure (HTRM) to assist clinicians in: (1) determining whether or not youth living with HIV are ready to initiate HAART and (2) identifying youth who may be in need of additional support services to facilitate their adherence to HAART. The current study will examine the psychometric properties of the HTRM and establish its test-retest reliability over a two week period. If the HTRM is found to be reliable, a subsequent study will examine its predictive validity.

HIV Infections

University of North Carolina, Chapel Hill200 participantsStarted May 2008

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +12 more locations

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

HIV Treatment-Readiness Measure (HTRM) Validation

Find Trials by Condition in Miami

Treatment De-Intensification and Residual HIV-1 in Youth

C2P Mobilization Intervention (Pilot)

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Factors Affecting PrEP Adherence

CDC-ATN Linkage Evaluation

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

Naltrexone/Bupropion Cardiovascular Outcomes Study

Linkage to Care - Part II

Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes